Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 10, 2007, Pages 1347-1352

  Sertic, Jadranka ^a,b   Slavicek, Jasna ^b   Bozina, Nada ^b   Malenica, Branko ^b   Kes, Petar ^b   Reiner, Zeljko ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

Atherosclerosis; Biochip; Cytokines; Growth factors; Hemodialysis; Inflammation

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BIOCHIP; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; PYELONEPHRITIS;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CYTOKINES; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; REFERENCE VALUES; RENAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

HEPATITIS C VIRUS;

EID: 35048892776     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.321     Document Type: Article

References (26)

1. Zimmerman J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-58.
2. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, et al. Interleukin 6 predicts hypoalbuminemia, hypercholesterolemia and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-14.
3. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-911.
4. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of mononuclear leukocyte adhesion molecule during atherosclerosis. Science 1991;251:788-91.
5. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
6. Blankerberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
8. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O. Elevated serum levels of soluble adhesion molecules in pre-dialysis patients: association with malnutrition, inflammation and cardiovascular disease. Nephrol Dial Transplant 2000;15:1624-30.
9. Papagianni A, Kokolina E, Kalovoluos M, Vainas A, Dimitriadis C, Memmos D. Carotid atherosclerosis is associated with inflammation, malnutrition and intercellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2004;19:1258-63.
10. Papagianni A, Kalovoluos M, Kirmizis D, Vainas A, Belechri AM, Alexopoulus E, et al. Carotid atherosclerosis is associated with inflammation and endothelial adhesion molecules in chronic haemodialisys patients. Nephrol Dial Transplant 2003;18:113-9.
11. Morita Y, Yamamura M, Kashihara N, Makino H. Increased production of interleukin-10 and inflammatory cytokines in blood monocytes of hemodialysis patients. Res Commun Mol Pathol Pharmacol 1997;98:19-33.
12. Girndt M, Sester U, Kaul H, Kohler H. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at single cell level. J Am Soc Nephrol 1998;9:1689-96.
13. Girndt M, Kohler H, Schieldhem-Weick E, Schlaak JF, Meyer zum Buschenfelde KH, Fleischer B. Production of interleukin-6, tumor necrosis factor α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 1995;47:559-65.
14. European Dialysis Transplant Association, European Renal Association. Report on management of renal failure in Europe. XXIV, 1993. Nephrol Dial Transplant 1995:10:1-25.
15. Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, et al. Mortality and hospitalisation in haemodialysis patients in five European countries: results from Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004;19:108-20.
16. Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, et al. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 2006;19:50-6.
17. Yano A, Nakao K, Sarai A, Akagi S, Kihara T, Morimoto H, et al. Elevated serum interleukin-18 levels might reflect the high risk of hospitalisation in patients on peritoneal dialysis. Nephrology 2005;10:576-82.
18. Berrahmoune H, Lamont JV, Herbeth B, FitzGerald P, Visvikis-Siest S. Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clin Chem 2006;52:504-10.
19. Sachdeva N, Yoon HS, Osima K, Garcia D, Goodkin K, Asthana D. Biochip array-based analysis of plasma cytokines in HIV patients with immunological and virological discordance. Scand J Immunol 2007;65:549-54.
20. Yu YM, Hou FF, Zhang X, Zhou H, Liu ZQ. Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogenesis. Zhonghua Nei Ke Za Zhi 2004;43:292-5.
21. Girndt M, Kaul H, Sester U, Ulrich C, Sester M, Georg T, et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002;62:949-55.
22. Seyrek N, Karayaylali I, Balal M, Paydas S, Aikimbaev K, Cetiner S, et al. Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients? Scand J Urol Nephrol 2005;39:405-9.
23. Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and proinflammatory cytokines. Nephrol Dial Transplant 2001;16:1189-97.
24. Berrahmoune H, Herbeth B, Lamont JV, Fitzgerald PS, Visvikis-Siest S. Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration. Atherosclerosis 2007;192:348-53.
25. Fitzgerald SP, Lamont JV, McConnell RI, Benchikh EO. Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 2005;51:1165-76.
26. Huang RP. Cytokine protein arrays. Methods Mol Biol 2004;264:215-31.